Skip to main content
OpenTrials

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

5,994 public trials 1,209 recruiting studies
Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Recruiting

Study of ONC206 (JZP3507) in Advanced Pheochromocytoma and Paraganglioma

NCT07282587

Conditions
Advanced Pheochromocytoma and Paraganglioma, Neoplasms, Neoplasms by Histologic Type, +6 more
Locations
  • UCLA Los Angeles, California, United States
  • Stanford Palo Alto, California, United States
  • U of Colorado Aurora, Colorado, United States
  • U of Michigan Ann Arbor, Michigan, United States
View Trial Details
Recruiting

Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma

NCT06934889

Conditions
Astrocytoma, Glioblastoma, Glioma, +8 more
Locations
  • University of California, Los Angeles (Data Collection Only) Los Angeles, California, United States
  • University of Miami (Data collection only) Miami, Florida, United States
  • Indiana University (Data Collection Only) Indianapolis, Indiana, United States
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
View Trial Details
Recruiting

Targeted Pediatric High-Grade Glioma Therapy

NCT05839379

Conditions
Anaplastic Astrocytoma, Astrocytoma, Brain Diseases, +24 more
Locations
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View all 21 locations
View Trial Details
Recruiting

Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.

NCT07165132

Conditions
Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +24 more
Locations
  • Research Facility Iowa City, Iowa, United States
  • Research Facility Lexington, Kentucky, United States
  • Research Facility St Louis, Missouri, United States
  • Research Facility St Louis, Missouri, United States
View Trial Details
Recruiting

Duration of Anti-PD-1 Therapy in Metastatic Melanoma

NCT02821013

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +10 more
Locations
  • Mildura Base Public Hospital Victoria, Mildura, Australia
  • Coffs Habour Health Campus - NCCI Coffs Harbour, New South Wales, Australia
  • Calvary Mater Newcastle Hospital Waratah, New South Wales, Australia
  • Westmead Hospital Westmead, New South Wales, Australia
View all 30 locations
View Trial Details

Related conditions